Late-onset agranulocytosis in a patient treated with clozapine and lamotrigine

Journal of Clinical Psychopharmacology

Volumn 31, Issue 5, 2011, Pages 665-667

  Tourian, Leon ^a   Margolese, Howard C ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; LAMOTRIGINE;

ADULT; AGRANULOCYTOSIS; CASE REPORT; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; NEUTROPHIL COUNT; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; AGRANULOCYTOSIS; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; FEMALE; HUMANS; SCHIZOPHRENIA, PARANOID; TIME FACTORS; TRIAZINES;

EID: 80052501214     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31822c29db     Document Type: Letter

References (15)

1. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45(9):789-796.
2. Buckley P, Miller A, Olsen J, et al. When symptoms persist: clozapine augmentation strategies. Schizophr Bull. 2001;27(4):615-628. (Pubitemid 34093248)
3. Dursun SM, McIntosh D, Milliken H. Clozapine plus lamotrigine in treatment-resistant schizophrenia. Arch Gen Psychiatry. 1999;56(10):950. (Pubitemid 29480132)
4. Kolivakis TT, Beauclair L, Margolese HC, et al. Long-term lamotrigine adjunctive to antipsychotic monotherapy in schizophrenia: further evidence. Can J Psychiatry. 2004;49(4):280. (Pubitemid 38608018)
5. Goff DC, Keefe R, Citrome L, et al. Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials. J Clin Psychopharmacol. 2007;27(6):582-589. (Pubitemid 351339444)
6. Yang TT, Wang SJ. Effects of haloperidol and clozapine on glutamate release from nerve terminals isolated from rat prefrontal cortex. Synapse. 2005;56(1):12-20.
7. Messenheimer JA. Lamotrigine. Epilepsia. 1995;36(suppl 2):S87-S94.
8. Stone JM, Morrison PD, Pilowsky LS. Glutamate and dopamine dysregulation in schizophreniaYa synthesis and selective review. J Psychopharmacol. 2007;21(4):440-452. (Pubitemid 47077295)
9. Hummer M, Kurz M, Barnas C, et al. Clozapine-induced transient white blood count disorders. J Clin Psychiatry. 1994;55(10):429-432.
10. Tamam L, Kulan E, Ozpoyraz N. Late onset neutropenia during clozapine treatment. Psychiatry Clin Neurosci. 2001;55(5): 547-548. (Pubitemid 32938812)
11. Elwes RD, Binnie CD. Clinical pharmacokinetics of newer antiepileptic drugs. Lamotrigine, vigabatrin, gabapentin and oxcarbazepine. Clin Pharmacokinet. 1996;30(6):403-415.
12. LeDrew K, Phillips L, Hogan M, et al. Lamotrigine-induced neutropenia. Can J Psychiatry. 2005;50(4):242.
13. Bhatt V, Saleem A. Review: drug-induced neutropeniaVpathophysiology, clinical features, and management. Ann Clin Lab Sci. 2004;34(2):131-137. (Pubitemid 38685904)
14. Alvir JM, Lieberman JA, Safferman AZ, et al. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl J Med. 1993;329(3):162-167. (Pubitemid 23195736)
15. Bhanji NH, Margolese HC, Chouinard G, et al. Late-onset agranulocytosis in a patient with schizophrenia after 17 months of clozapine treatment. J Clin Psychopharmacol. 2003;23(5):522-523. (Pubitemid 37128684)